<DOC>
	<DOCNO>NCT01391559</DOCNO>
	<brief_summary>Some patient Chronic Obstructive Pulmonary Disease ( COPD ) report uncertain whether achieve clinical benefit use dry-powder inhaler ( DPI ) . One possible explanation patient unable inhale dry powder bronchodilator medication lower respiratory tract due low peak inspiratory flow rate ( PIFR ) . A PIFR &lt; 60 l/min consider suboptimal flow DPI , include Diskus device . The hypothesis study force expiratory volume 1 second ( FEV1 ) measure two hour inhalation study medication high arformoterol solution ( 15 mcg ) nebulizer compare salmeterol dry powder ( 50 mcg ) inhale Diskus .</brief_summary>
	<brief_title>Efficacy Inhaling Bronchodilator Medications Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Bronchodilator Agents</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>male female patient 60 year age old ; diagnosis COPD ; current former smoker ; previous current use Diskus device ; PIFR &lt; 60 l/min use Incheck DIAL resistance Diskus device ; clinically stable . patient concomitant disease might interfere study procedure evaluation ; inability withhold shortacting longacting bronchodilator day test</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>breathe difficulty</keyword>
</DOC>